Patient Analytics from Chryselys moves beyond static dashboards and demographic summaries. It provides a dynamic, longitudinal view of the patient journey—integrating real-world data sources like claims, EHR, lab, SDoH, and even wearables. This 360° lens uncovers not just what patients do, but why they do itenabling targeted interventions that improve outcomes and brand performance.
From identifying rising-risk patients and mapping referral leakages to understanding therapy switch triggers, this solution turns complexity into clarity, helping teams act faster, smarter, and with more precision.
A scalable, vendor-agnostic data architecture that fuses claims, labs, EHR notes, and SDoH into a stable, longitudinal view.
Sankey flows and interactive diagrams help track thousands of patient pathways, enabling better segmentation and targeting.
Proprietary ML models with >75% accuracy forecast therapy switching, allowing field teams to act before churn happens.
Pinpoint high-risk patients by layering clinical deterioration and utilization trends for early intervention.
Analyze unstructured narratives like call logs or social listening data to bring empathy into evidence.
Factor in real-world barriers like income, transport, or housing to refine your support strategies and improve health equity.
Uniquely combines structured datasets with qualitative insights from the patient voice.
Nudges and alerts pushed directly into your reps’ daily tools.
Oncology LoT logic, rare disease phenotyping, and more.
Fully HIPAA/GDPR-compliant, works across any data vendor without lock-in.
Flag therapy discontinuation risks before they happen.
Identify and act on high-leakage referral zones.
Find undiagnosed patients using AI signals.
Prioritize patients who need human touchpoints based on risk and SDoH.
Use natural language prompts to get instant answers from integrated datasets.
Deploy targeted interventions and retain patients by identifying drop-off risks early.
Understand “moments that matter” and personalize messaging to patient archetypes like switchers or initiators.
Demonstrate adherence, outcomes, and economic value through robust RWE.
Accelerate trial recruitment and rare disease detection via phenotype-based models.
Visualize referral patterns and detect “leakage” to focus outreach on the right providers.
Revolutionize your business trajectory and achieve unprecedented growth with our committed partnership
